IL6 and metabolic dysfunction-associated steatotic liver disease: In addition, FFDZ administration significantly reversed the increase in inflammatory cytokines (IL-6 and TNF-α) in HFD-induced NAFLD mice, which are key markers of NAFLD progression to NASH (Duan et al., 2022).